Boehringer Ingelheim Expands Capabilities in Biopharmaceutical Process Science

News   Mar 15, 2012

 
Boehringer Ingelheim Expands Capabilities in Biopharmaceutical Process Science
 
 
 

RELATED ARTICLES

Sekisui XenoTech Appoints New COO

News

Company hires CRO & pharma veteran, Dr. Darren Warren, as new Chief Operating Officer.

READ MORE


Biomarker for Glioblastoma Predicts Clinical Course and Sensitivity to Treatment

News

Scientists validate a biomarker indicative of patients with Glioblastoma prognosis and likely response to specific therapies.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE